These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1725904)

  • 1. Modulation of circulating endothelin levels in hypertension and endotoxemia in rats.
    Vemulapalli S; Chiu PJ; Rivelli M; Foster CJ; Sybertz EJ
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):895-903. PubMed ID: 1725904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
    Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of endothelin-1 in spontaneously hypertensive rats and DOCA-salt hypertensive rats.
    Suzuki N; Miyauchi T; Tomobe Y; Matsumoto H; Goto K; Masaki T; Fujino M
    Biochem Biophys Res Commun; 1990 Mar; 167(3):941-7. PubMed ID: 2182029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma endothelin-1 levels in obese hypertensive and normotensive men.
    Ferri C; Bellini C; Desideri G; Di Francesco L; Baldoncini R; Santucci A; De Mattia G
    Diabetes; 1995 Apr; 44(4):431-6. PubMed ID: 7698512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma level of endothelin-1 in the Okamoto spontaneously hypertensive rat.
    Khraibi AA; Heublein DM; Knox FG; Burnett JC
    Mayo Clin Proc; 1993 Jan; 68(1):42-6. PubMed ID: 8417254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
    Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of endogenous endothelin release in the anesthetized rat.
    Pollock DM; Divish BJ; Opgenorth TJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S295-8. PubMed ID: 7509969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central effects of endothelin and its antagonists on sympathetic and cardiovascular regulation in SHR-SP.
    Nakamura K; Sasaki S; Moriguchi J; Morimoto S; Miki S; Kawa T; Itoh H; Nakata T; Takeda K; Nakagawa M
    J Cardiovasc Pharmacol; 1999 Jun; 33(6):876-82. PubMed ID: 10367590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma immunoreactive endothelin-1 in experimental malignant hypertension.
    Kohno M; Murakawa K; Horio T; Yokokawa K; Yasunari K; Fukui T; Takeda T
    Hypertension; 1991 Jul; 18(1):93-100. PubMed ID: 1860718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the flavonoid fraction of Lithocarpus polystachyus Rehd. on spontaneously hypertensive and normotensive rats.
    Hou SZ; Xu SJ; Jiang DX; Chen SX; Wang LL; Huang S; Lai XP
    J Ethnopharmacol; 2012 Sep; 143(2):441-7. PubMed ID: 22820240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin: role in hypertension.
    Schiffrin EL
    Biol Res; 1998; 31(3):199-208. PubMed ID: 9830507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of endothelin-3 on blood pressure in conscious spontaneously hypertensive [SHR] and DOCA-salt hypertensive rats.
    Januszewicz A; Loń S; Lapiński M; Styś A
    J Physiol Pharmacol; 1994 Mar; 45(1):105-19. PubMed ID: 8043901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay.
    Sugiura M; Inagami T; Kon V
    Biochem Biophys Res Commun; 1989 Jun; 161(3):1220-7. PubMed ID: 2662974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive endothelin-1 contents in brain regions from spontaneously hypertensive rats.
    Yoshimi H; Kawano Y; Akabane S; Ashida T; Yoshida K; Kinoshita O; Kuramochi M; Omae T
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S417-9. PubMed ID: 1725397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular reactivity, tissue levels, and binding sites for endothelin: a comparison in the spontaneously hypertensive and Wistar-Kyoto rats.
    Bolger GT; Liard F; Jodoin A; Jaramillo J
    Can J Physiol Pharmacol; 1991 Mar; 69(3):406-13. PubMed ID: 1647848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
    Larivière R; Sventek P; Thibault G; Schiffrin EL
    Can J Physiol Pharmacol; 1995 Mar; 73(3):390-8. PubMed ID: 7544236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure responses to intravenous or intracerebroventricular endothelin-1 in spontaneously hypertensive rats.
    Yoshida K; Kawano Y; Yoshimi H; Kuramochi M; Omae T
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S297-9. PubMed ID: 1725361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous insulin modulates circulating endothelin-1 concentrations in humans.
    Ferri C; Bellini C; Desideri G; De Mattia G; Santucci A
    Diabetes Care; 1996 May; 19(5):504-6. PubMed ID: 8732718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-mediated effect of erythropoietin on blood pressure and renal hemodynamics in hypertensive rats.
    Tojo A; Doumoto M; Oka K; Numabe A; Kimura K; Yagi S
    Am J Physiol; 1996 Apr; 270(4 Pt 2):R744-8. PubMed ID: 8967402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.